← Leaderboards
David D Tran
Washington University
$4,389,335
Attributed
$6,026,890
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,026,890 · 3
By mechanism
R01$2,810,402 · 1
R42$2,456,333 · 1
K08$760,155 · 1
Top collaborators
- Sergei Zolotukhin4 shared
- Darin J Falk3 shared
- Kenneth H Warrington1 shared
Most similar at Washington University
Same institution · by research overlap
- Jacqueline E. Payton$4,312,454
- Ali Hassan Ellebedy$14,119,121
- John A Olson$6,092,537
- Peter Westervelt$8,274,820
- Li Ding$30,836,856
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelSignal PathwayCellsBaseMalignant NeoplasmsMesenchymalPrimary NeoplasmNeoplastic CellPathway InteractionsParacrineMalignant Breast NeoplasmAutocrineNeoplasm MetastasisChemotherapyCytokine Network PathwayRegimenMaintenanceBone MarrowDistantGenomicsGrowthInterleukin-6Cancer EtiologyResistance
Grant awards (15)
Novel Methods of Chemo-sensitizing Low-proliferative Disseminated Tumor Cells in Triple Negative Breast Cancer$565,690
R01 · FY2025 · CA · contact PI
Novel Methods of Chemo-sensitizing Low-proliferative Disseminated Tumor Cells in Triple Negative Breast Cancer$1
R01 · FY2024 · CA · contact PI
Novel Methods of Chemo-sensitizing Low-proliferative Disseminated Tumor Cells in Triple Negative Breast Cancer$621,513
R01 · FY2023 · CA · contact PI
Novel Methods of Chemo-sensitizing Low-proliferative Disseminated Tumor Cells in Triple Negative Breast Cancer$557,734
R01 · FY2022 · CA · contact PI
Novel Methods of Chemo-sensitizing Low-proliferative Disseminated Tumor Cells in Triple Negative Breast Cancer$543,700
R01 · FY2021 · CA · contact PI
Targeting glioblastoma stem-like cells with custom-designed viral vectors$999,999
R42 · FY2020 · CA
Novel Methods of Chemo-sensitizing Low-proliferative Disseminated Tumor Cells in Triple Negative Breast Cancer$521,764
R01 · FY2020 · CA · contact PI
Targeting glioblastoma stem-like cells with custom-designed viral vectors$999,999
R42 · FY2019 · CA
Targeting glioblastoma stem-like cells with custom-designed viral vectors$156,335
R42 · FY2019 · CA
Targeting glioblastoma stem-like cells with custom-designed viral vectors$300,000
R42 · FY2018 · CA
Role of Twist1 in EMT Maintenance and tumor dormancy$152,031
K08 · FY2017 · CA · contact PI
Role of Twist1 in EMT Maintenance and tumor dormancy$152,031
K08 · FY2016 · CA · contact PI
Role of Twist1 in EMT Maintenance and tumor dormancy$152,031
K08 · FY2015 · CA · contact PI
ROLE OF TWIST1 IN EMT MAINTENANCE AND TUMOR DORMANCY$152,031
K08 · FY2014 · CA · contact PI
ROLE OF TWIST1 IN EMT MAINTENANCE AND TUMOR DORMANCY$152,031
K08 · FY2013 · CA · contact PI